Healio |
Diabetes vaccine may follow from celiac disease research
Healio The venture philanthropy organization JDRF T1D Fund is investing in ImmusanT, a clinical-stage company looking to develop a vaccine to prevent type 1 diabetes following on its peptide immunotherapy program for celiac disease, the two entities announced ... |
Online Degree Proram MBA
No comments:
Post a Comment